IRIS
ANGELUCCI, ADRIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.606
EU - Europa 3.108
AS - Asia 1.256
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 6
SA - Sud America 6
Totale 8.991
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.591
IE - Irlanda 1.003
CN - Cina 702
TR - Turchia 492
SE - Svezia 471
DE - Germania 433
IT - Italia 324
UA - Ucraina 276
GB - Regno Unito 268
FI - Finlandia 136
FR - Francia 129
BE - Belgio 30
IN - India 20
CA - Canada 14
EU - Europa 9
KR - Corea 9
NL - Olanda 8
VN - Vietnam 8
SG - Singapore 7
BR - Brasile 6
ES - Italia 5
TW - Taiwan 5
AU - Australia 4
RU - Federazione Russa 4
HU - Ungheria 3
IL - Israele 3
SI - Slovenia 3
BG - Bulgaria 2
BN - Brunei Darussalam 2
CH - Svizzera 2
DK - Danimarca 2
JP - Giappone 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
AL - Albania 1
AT - Austria 1
BD - Bangladesh 1
CR - Costa Rica 1
HK - Hong Kong 1
IR - Iran 1
IS - Islanda 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MY - Malesia 1
PL - Polonia 1
PT - Portogallo 1
SA - Arabia Saudita 1
Totale 8.991
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.102
Chandler 1.022
Dublin 1.000
Izmir 257
Nanjing 228
Boardman 215
San Mateo 200
Wilmington 165
Lawrence 145
Princeton 145
New York 139
Ann Arbor 127
Bremen 117
Ashburn 99
L'aquila 89
Nanchang 61
Woodbridge 61
Beijing 60
Milan 60
Seattle 60
Shenyang 53
Mountain View 49
Des Moines 40
Hebei 39
Jiaxing 39
Verona 35
Tianjin 30
Brussels 29
Strasbourg 28
Kunming 27
Falls Church 21
Zhengzhou 21
Shanghai 20
Torre Del Greco 20
Changsha 19
Ningbo 19
Dearborn 18
Jinan 18
Norwalk 17
Los Angeles 16
Philadelphia 16
Hangzhou 13
Helsinki 12
Guangzhou 11
L’Aquila 11
Pune 11
Taizhou 11
Düsseldorf 9
Lanzhou 9
Tappahannock 9
Aquila 8
Dong Ket 8
Grafing 8
Rome 8
Fremont 7
Belfast 6
Houston 6
Little Rock 6
Pescara 6
Auburn Hills 5
San Francisco 5
Edinburgh 4
Redwood City 4
Toronto 4
Budapest 3
Cagliari 3
Cedar Knolls 3
Changchun 3
Delhi 3
Domodossola 3
Frankfurt am Main 3
Miglianico 3
Ottawa 3
Washington 3
Auckland 2
Bandar Seri Begawan 2
Bologna 2
Chongqing 2
Copenhagen 2
Fuzhou 2
Hanover 2
Lombard 2
Lugones 2
Madrid 2
Menlo Park 2
Molfetta 2
Montreal 2
Naples 2
Oslo 2
Recife 2
São Paulo 2
Venezia 2
Wuhan 2
Alba 1
Almaty 1
Amsterdam 1
Andover 1
Angra dos Reis 1
Antwerpen 1
Baotou 1
Totale 6.182
Salva come PNG Salva come JPEG
Nome #
Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression 102
Combining X-ray Crystallography and Molecular Modeling toward the Optimization of Pyrazolo[3,4-d]pyrimidines as Potent c-Src Inhibitors Active in Vivo against Neuroblastoma 96
A gene expression signature from bone metastases as predictor of clinical outcome in breast cancer patients 91
The unexpected role of Hemoglobin beta (HBB) in breast cancer. 90
Serum 25(OH)D seasonality in urologic patients from central Italy 90
Adipose-derived stem cells sustain prolonged angiogenesis through leptin secretion 87
Clinical correlates of plasma brain-derived neurotrophic factor in post-traumatic stress disorder spectrum after a natural disaster 86
Trattamento con Casodex ed Iressa nel tumore della prostata: evidenze biologiche a favore 84
"Vessels in the Storm": Searching for Prognostic and Predictive Angiogenic Factors in Colorectal Cancer 84
Obesity in the elderly - On the role of adipokines in prostate cancer progression 80
Pyrazolo[3,4-d]pyrimidine Prodrugs: Strategic Optimization of the Aqueous Solubility of Dual Src/Abl Inhibitors 79
Leptin contributes to long-term stabilization of HIF-1α in cancer cells subjected to oxygen limiting conditions 78
Design, Synthesis, and Biological Evaluation of Pyrazolo[3,4-d]pyrimidines Active in Vivo on the Bcr-Abl T315I Mutant 77
Between-subject variations of transition zone epithelial volume and serum PSA levels in men with benign prostatic hyperplasia 77
Tissue print of prostate biopsy: a novel tool in the diagnostic procedure of prostate cancer 77
Osteoblast-derived TGF beta-1 modulates matrix degrading protease expression and activity in prostate cancer cells (vol 85, pg 407, 2000) 77
Arachidonic acid modulates the crosstalk between prostate carcinoma and bone stromal cells 75
Apoptosis or programmed cell death 75
Additive antitumor effects of the epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib (Iressa), and the nonsteroidal antiandrogen, bicalutamide (Casodex), in prostate cancer cells in vitro 75
c-Src inhibition decreases breast cancer-induced lethality and incidence of metastases in nude mice. 75
Bone-Targeted Doxorubicin-Loaded Nanoparticles as a Tool for the Treatment of Skeletal Metastases 75
Antiproliferative and proapoptotic activities of new pyrazolo[3,4-d]pyrimidine derivative Src kinase inhibitors in human osteosarcoma cells 74
Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines 73
L'acido valproico è un potente induttore di apoptosi nelle linee di carcinoma prostatico 73
La ridondanza delle vie di segnalazione intracellulari PI3K-AKT-MTOR induce la resistenza di cellule di cancro prostatico alla terapia ormonale ed ai chemoterapici in vivo ed in vitro 73
Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines 73
SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiation 73
Valproic acid induces apoptosis in prostate carcinoma cell lines by activation of multiple death pathways 72
Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination 72
Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells 72
INIBITORI DI METALLOPROTEASI DI MATRICE: PROSPETTIVE TERAPEUTICHE. EOS - JOURNAL OF IMMUNOLOGY AND IMMUNOPHARMACOLOGY, VOL.XXI – 2001 – N.1: 22-27 72
A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitors 72
Aging influences the Value of Serum Leptin as Prostate Cancer Risk Factor 72
Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samples 71
Therapeutic potential of Askina® Gel in regenerative medicine 71
Effetto di Getifinib sulla crescita e la formazione di metastasi nel tumore della prostata in vivo 71
Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases 70
Targeting ERBB receptors to inhibit metastasis: old hopes and new certainties 70
Src inhibition potentiates antitumoral effect of paclitaxel by blocking tumor-induced angiogenesis. 70
Suppression of SRC signaling is effective in reducing synergy between glioblastoma and stromal cells 70
Arachidonic acid sustains prostate tumor growth in bone metastasis through the COX-2-mediated production of TNF-alpha 69
Receptor Activator of NF-kappa B Ligand Enhances Breast Cancer-Induced Osteolytic Lesions through Upregulation of Extracellular Matrix Metalloproteinase Inducer/CD147 69
A new inhibitor of EGFR/SRC activation is able to block several key molecular events in prostate cancer progression 69
INHIBITION OF 5-ALPHA-REDUCTASE ISOFORMS IN PROSTATE CARCINOMA PRIMARY CULTURES 69
Tamsulosin treatment increases clinical success rate of single extracorporeal shock wave lithotripsy of renal stones 69
Kinase-dependent and independent role of EphA2 in the regulation of prostate cancer invasion and metastasis 69
Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and Matrigel invasion 69
THE IMPACT OF SERUM LEPTIN AS BIOMARKER OF PROSTATE CANCER INCREASES WITH AGEING 69
Studies on the ATP Binding Site of Fyn Kinase for the Identification of New Inhibitors and Their Evaluation as Potential Agents against Tauopathies and Tumors 68
Culture conditions modulate cell phenotype and cause selection of subpopulations in PC3 Prostate Cancer Cell Line 68
Introductory Immunology 68
Non-conventional role of haemoglobin beta in breast malignancy 68
NEW 4-SUBSTITUTED DERIVATIVES OF PYRAZOLO [3,4-D] PYRIMIDINE AND PYRROLO [2,3-D] PYRIMIDINE AND USES THEREOF 67
An overview of the effect of linoleic and conjugated-linoleic acids on the growth of several human tumor cell lines 67
Indolyl-pyrrolone as a new scaffold for Pim1 inhibitors 66
Inhibition of Angiogenesis Mediated by Extremely Low-Frequency Magnetic Fields (ELF-MFs) 66
Expression of Peroxisome Proliferator-Activated Receptor alpha (PPARα) in somatotropinomas: Relationship with Aryl hydrocarbon receptor Interacting Protein (AIP) and in vitro effects of fenofibrate in GH3 cells 66
Apoptosi e sistema immunitario: regolazione e patologie associate 65
Identification of Aminoimidazole and Aminothiazole Derivatives as Src Family Kinase Inhibitors 65
Bombesin-dependent Pro-MMP-9 activation in Prostatic Cancer cells requires beta-1 integrin engagement 64
The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering 64
Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures 63
Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice 63
Bicalutamide dose-dependently inhibits proliferation in human prostatic carcinoma cell lines and primary cultures 63
Molecular pathogenesis of bone metastases in breast cancer: Proven and emerging therapeutic targets. 63
Identification of a novel pyrazolo[3,4-d]pyrimidine able to inhibit cell proliferation of a human osteogenic sarcoma in vitro and in a xenograft model in mice 63
Pyrazolo[3,4-d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cells 62
Surgical and Biologic Outcomes After Neoadjuvant Bicalutamide Treatment in Prostate Cancer 62
Co-evolution of stroma and neoplastic cells in prostate cancer is sustained by reprogramming energy metabolism 62
Therapeutic potential of a biomatrix (Askina gel) in regenerative medicine 62
LA VALUTAZIONE DELL’ATTIVITA’ TELOMERASICA SU MASSAGGIO PROSTATICO PERMETTE DI MIGLIORARE LA DIFFERENZIAZIONE TRA LA PATOLOGIA TUMORALE PROSTATICA E L’IPERPLASIA PROSTATICA BENIGNA 62
Inhibition of tyrosine kinase c-Src improves experimental breast cancer metastatic disease. Implication for therapy 62
Evaluation of metastatic potential in prostate carcinoma: An in vivo model 61
Identification of potent c-Src inhibitors strongly affecting the proliferation of human neuroblastoma cells 61
Osteoblast-conditioned media stimulate membrane vesicle shedding in prostate cancer cells 61
Pro-angiogenic potential of adipose derived mesenchimal stem cells (AD-MSCs) in hypoxic condition 61
Suberoylanilide hydroxamic acid partly reverses resistance to paclitaxel in human ovarian cancer cell lines 60
A set of genes expressed in breast cancer bone metastases discloses predisposition to generate metastases in multiple organs 60
Antiproliferative and pro-apoptotic effects afforded by novel Src-kinase inhibitors in human neuroblastoma cells 60
Cancer Multitarget Pharmacology in Prostate Tumors: Tyrosine Kinase Inhibitors and Beyond 60
Novel tyrosine kinase inhibitors active against a wide panel of tumor cell lines 59
Plasma brain-derived neurotrophic factor in earthquake survivors with full and partial post-traumatic stress disorder 59
Effects of 5 alpha reductase inhibitors on androgen-dependent human prostatic carcinoma cells 59
New pyrazolo-[3,4-d]-pyrimidine derivative Src kinase inhibitors lead to cell cycle arrest and tumor growth reduction of human medulloblastoma cells 59
Mechanisms underlying the anti-tumoral effects of Citrus Bergamia juice 58
NEUROENDOCRINE TRANSDIFFERENTIATION INDUCED BY HDAC INHIBITORS CONFERS RESISTANCE TO ANTIBLASTIC THERAPY IN PROSTATE CARCINOMA 58
Possibile anti-apoptotic activity of carnitines on excitatory amino acid induced neurotoxicity 58
ENERGY METABOLISM OF PROSTATE CANCER CAN BE SUPPORTED BY REVERSE WARBURG EFFECT 57
Chemically stable inhibitors of 14-3-3 protein–protein interactions derived from BV02 57
Reduction of glutamate levels in HIV-infected subjects treated with acetylcarnitine 57
Effects of Dutasteride on Prostate Carcinoma Primary Cultures: A Comparative Study With Finasteride and MK386 56
Trattamento con casodex ed iressa nel tumore della prostata: evidenze biologiche a favore. 56
Detection of telomerase activity in prostate massage samples improves differentiating prostate cancer from benign prostatic hyperplasia 56
Inhibition of protein kinase c-src reduces the incidence of breast cancer metastases and increases survival in mice: Implications for therapy 56
Fenomeni adattativi dopo terapia antiandrogenica nel tumore della prostata 56
Neuroendocrine transdifferentiation induced by VPA is mediated by PPARgamma activation and confers resistance to antiblastic therapy in prostate carcinoma 55
Verso una teoria ecologica dei tumori 55
LA TERAPIA ANTIANDROGENICA FAVORISCE L’INSORGENZA DELL’ANDROGENO INDIPENDENZA AUMEN-TANDO L’ESPRESSIONE DEL RECETTORE PER IL FATTORE DI CRESCITA EPIDERICO 55
EphA2 induces metastatic growth regulating amoeboid motility and clonogenic potential in prostate carcinoma cells 55
Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program 55
Totale 6.815
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.280
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.280
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019412 0 0 0 0 0 0 0 0 0 0 41 371
2019/20201.196 278 12 141 9 3 171 210 11 153 31 11 166
2020/20211.231 27 143 4 149 149 52 160 11 161 59 255 61
2021/2022980 63 88 183 66 43 23 15 52 48 33 82 284
2022/20233.005 198 157 57 314 346 321 3 214 1.238 19 90 48
2023/2024647 99 45 40 126 53 215 12 37 2 17 1 0
Totale 9.097